IsoRay (ISR) Announces Cesium-131 Selected For Use in Study by Chicago Prostate Cancer Center
Tweet Send to a Friend
IsoRay, Inc. (NYSE: ISR), a medical technology company and innovator in brachytherapy and medical isotope applications, today announced that Dr ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE